{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["2(8)"],"submitter":["Sharrock KC"],"pubmed_abstract":["This paper presents data on selected indicators to show progress towards elimination goals and targets for hepatitis B and hepatitis C in the 31 countries of the European Union (EU) and European Economic Area (EEA). A monitoring system was developed by the European Centre for Disease Prevention and Control, which combined newly collected data from EU/EEA countries along with relevant data from existing sources. Data for 2017 were collected from the EU/EEA countries via an online survey. All countries provided responses. In 2017, most countries reporting data had not reached prevention targets for childhood hepatitis B vaccination and for harm reduction services targeting people who inject drugs (PWID). Four of 12 countries had met the target for proportion of people living with chronic HBV"],"journal":["PLOS global public health"],"pagination":["e0000841"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10022013"],"repository":["biostudies-literature"],"pubmed_title":["Monitoring progress towards elimination of hepatitis B and C in the EU/EEA."],"pmcid":["PMC10022013"],"pubmed_authors":["Diaz A","Veldhuijzen I","James C","Ruutel K","Sharrock KC","Klavs I","Maticic M","Hendrickx G","Rigoni R","Korenjak M","Buti M","Seyler T","Fursa O","Noori T","Rosinska M","Peters L","Schatz E","Duffell E","Axelsson M","Mozalevskis A"],"additional_accession":[]},"is_claimable":false,"name":"Monitoring progress towards elimination of hepatitis B and C in the EU/EEA.","description":"This paper presents data on selected indicators to show progress towards elimination goals and targets for hepatitis B and hepatitis C in the 31 countries of the European Union (EU) and European Economic Area (EEA). A monitoring system was developed by the European Centre for Disease Prevention and Control, which combined newly collected data from EU/EEA countries along with relevant data from existing sources. Data for 2017 were collected from the EU/EEA countries via an online survey. All countries provided responses. In 2017, most countries reporting data had not reached prevention targets for childhood hepatitis B vaccination and for harm reduction services targeting people who inject drugs (PWID). Four of 12 countries had met the target for proportion of people living with chronic HBV","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-05T11:30:00.029Z","creation":"2025-02-19T02:25:34.225Z"},"accession":"S-EPMC10022013","cross_references":{"pubmed":["36962761"],"doi":["10.1371/journal.pgph.0000841"]}}